These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9176768)

  • 41. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional differences in hepatocellular carcinoma and its surgical treatment.
    Ezaki T; Stansby GP; Hobbs KE
    HPB Surg; 1991 Jun; 4(2):121-8. PubMed ID: 1657117
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.
    Curley SA; Izzo F; Gallipoli A; de Bellis M; Cremona F; Parisi V
    Ann Surg; 1995 Sep; 222(3):375-80; discussion 380-3. PubMed ID: 7677466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Screening for hepatocellular carcinoma in cirrhotic patients].
    Beaugrand M
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis viruses and hepatocarcinogenesis].
    Kaneko S; Unoura M; Kobayashi K
    Gan To Kagaku Ryoho; 1993 May; 20(7):858-63. PubMed ID: 8387755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Informed consent for high risk group of hepatocellular carcinoma].
    Yamada G
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():812-6. PubMed ID: 11762062
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatocellular carcinoma. Part 1. General considerations and diagnosis].
    Conte VP
    Arq Gastroenterol; 2000; 37(1):58-68. PubMed ID: 10962630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The epidemiology of hepatocellular carcinoma.
    Johnson PJ
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM; Lu SN
    Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A.
    Lancet; 1979 Feb; 1(8113):433-4. PubMed ID: 84277
    [No Abstract]   [Full Text] [Related]  

  • 58. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C virus and hepatocellular carcinoma.
    Kiyosawa K; Furuta S
    Curr Stud Hematol Blood Transfus; 1994; (61):98-120. PubMed ID: 7525158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.